Don't Lose Heart

Co-Moderator(s)

• 

  Elena Rivero-Ferrer, MD, MPH, FISPE (she/her/hers)

  Senior Director, Epidemiology
  RTI Health Solutions
  BARCELONA, Spain
• 

  Elizabeth Bell, PhD, MPH (she/her/hers)

  Senior Epidemiologist
  Optum Epidemiology
  Minneapolis, United States

Presentations:

• 8:00 AM – 8:15 AM ADT

  Signal Evaluation Using Observational Databases to Examine Methylphenidate Use and the Risk of Epistaxis
  

  Presenting Author: David M. Kern, PhD, MS – Janssen Research & Development
• 8:15 AM – 8:30 AM ADT

  Statin use and the risk of cancer in patients with heart failure: a target trial emulation
  

  Presenting Author: Chengsheng Ju, MPharm (he/him/his) – Research Department of Practice and Policy, School of Pharmacy, University College London, London, United Kingdom
• 8:30 AM – 8:45 AM ADT

  Sequential Safety Monitoring of Rofecoxib for Cardiovascular Adverse Effects
  

  Presenting Author: Saad Hanif Abbasi, PhD. student – Clinical Pharmacology, Pharmacy and Environmental Medicine, Department of Public Health, University of Southern Denmark
• 8:45 AM – 9:00 AM ADT

  Impact of beta-blockers on mortality and cardiovascular disease outcomes in patients with obstructive sleep apnoea: a target trial emulation study
  

  Presenting Author: Anthony Chen, BSc, MSc (he/him/his) – University of Nottingham
• 9:00 AM – 9:15 AM ADT

  Cardiovascular safety of ibuprofen use for acute pericarditis: A Danish population-based cohort study
  

  Presenting Author: Kasper Bonnesen, MD, PhD (he/him/his) – Department of Clinical Epidemiology, Aarhus University Hospital and Aarhus University
• 9:15 AM – 9:30 AM ADT

  Sclerostin inhibition, cardiovascular biomarkers, risk factors, and clinical outcomes: a Mendelian randomisation analysis using UK Biobank data
  

  Presenting Author: Marta Alcalde-Herraiz – Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford